Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

Non-adherence to at least one prescribed antidiabetic drug is highly common among patients with type 2 diabetes and rises ...

The drug, called Rybelsus, is the only oral GLP-1 medication available. It was previously approved to treat Type 2 diabetes ...

Diabetes is a dangerous and chronic inflammatory disease; its treatment typically includes medication and modification in ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Genetic screening can mean that people at risk of type 1 diabetes get earlier treatment and better outcomes This article is ...

In 2024 Stephen Rich and his colleagues published a study in which they assessed the genetic risk of developing type 1 ...

Drinking coffee with certain prescription or over-the-counter medications can reduce their effectiveness or cause dangerous ...

There's mounting evidence that popular drugs prescribed for diabetes management and weight loss—better known by trade names ...